Monday December 11, 2017
Home India Private hospi...

Private hospitals deny access: Dengue claims son, Parents commit suicide

0
87
source: www.cafleurebon.com

dengueBy Newsgram Staff Writer

New Delhi: Lakshman Chandra Raut (35) and Babita Raut (30) committed suicide by jumping from the fourth floor of a building when their seven-year-old son Avinash Raut died of dengue, said Delhi Police on Saturday.

Police said the couple hailing from Odisha jumped from their rented accommodation in the Lado Sarai area of south Delhi on Wednesday around 12.15 am. The parents have left a suicide note in Odia explaining that they were responsible for their own actions.

A suicide note was also recovered from the possession of the couple in which it was mentioned that they were in extreme shock over the death of their son. The note was written in Odia. The couple also mentioned that nobody is responsible for their act and that they were responsible for their decision,” the officer said.

After being diagnosed with the symptoms of dengue, Avinash was denied admission in five private hospitals, police said. He was finally admitted on September 4 but died during treatment on September 8, unable to make up for the lost time.

The Delhi government has issued a show-cause notice to these hospitals.

Moolchand Khairati Ram Hospital, Aakash Hospital, Saket City Hospital, Max Hospital (Saket) and Irene Hospital (Kalkaji) have been asked to reply in a month as to why their registration should not be cancelled for refusing emergency medical care to the deceased child,” said a Delhi government official.

While Health Minister Satyendra Jain promised stringent steps to be taken in the case, the Union Health Minister J.P. Nadda went a step further: “I have ordered an inquiry into the incident reported in the media involving the death of a child in Delhi due to dengue and the suicide by his parents. Guilty won’t be spared.”

The Central government is  also probing into the matter.

(With inputs from IANS)

 

Next Story

Delhi records 3,829 cases of dengue, 502 of chikungunya till date

The year 2015 had reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

0
27
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

New Delhi, November 7, 2017 :  Delhi has so far recorded 3,829 cases of dengue and 502 cases of chikungunya, according to civic agencies on Monday.

While the national capital has witnessed a total of four dengue-related deaths till now, no deaths have been reported due to chikungunya.

ALSO READ You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

The year 2015 reported the highest number of cases of dengue in the city, with the figure standing at 15,867 with 60 deaths.

As for chikungunya, 2016 saw 7,117 cases — the highest in the last five years.

Civic agencies said that areas under the South Delhi Municipal Corporation reported the maximum cases of chikungunya and dengue this year.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

Delhi has also reported a total of 552 malaria cases with no deaths so far. The figure is the second-highest after 2012 when the cases had soared to 822. (IANS)

Next Story

Do You Know there are only two Leaning Temples in The World? Visit the Leaning Temple of Huma in Sambalpur

Huma is about 23 kms towards the southern direction of Sambalpur, Odisha. and is connected with Sambalpur and other cities of Orissa by road. The temple is situated inside the village of Huma.

0
121
Leaning Temple
The Leaning Temple of Huma. Wikimedia.

The famous Leaning Temple of Huma built in 1670 AD is dedicated to Lord Shiva. This temple is one of the only two leaning temples in the world. It was constructed by the ruler, Baliar Singh, the 5th ruler of the kingdom of Chauhan of Sambalpur, Odisha, India. The speciality of this temple is it’s structure skewed to one direction.

Reason Behind its Tilted Structure:

It is regarded that the reason for its tilted structure could be some interior dismounting of rocky bed at which this temple is positioned, either because of flood current inside the Mahanadi River or earthquake, thereby affecting the position of this original temple.  An interesting fact to be noted is that the other little temples inside the Hamlet are also tilted to various other directions.

The finest time to visit this leaning temple is October to March. Enshrine your spirituality during these months and celebrate the festive season in the town of Sambalpur, Odisha. Shivratri is believed to be the chief festival of this temple. Hence, it advances a huge gathering specially during Shivratri festival during March. You may also find ‘Kudo’ fishes on the bank of river Mahanadi near the temple who are given food by devotees as a part of the worship.

Leaning Temple
The Leaning Temple of Huma. Wikimedia.

How to Reach the Leaning Temple of Huma:

By Road – Huma is about 23 kms towards the southern direction of Sambalpur, Odisha. and is connected with Sambalpur and other cities of Orissa by road. The temple is situated inside the village of Huma.

By Rail – Sambalpur railway station is the closest station from Huma. You may find taxis and cabs to drop you 23 kms towards the temple of Huma.

By Air – Bhubaneshwar is the closest airport to Huma which is approximately 290 ms away from Huma. Catch a taxi or cab to drop you at the exact destination.

Leaning Temple
Huma Leaning Temple is one of the two leaning temples of the world. Wikimedia.

Where to stay:

There are various hotels nearby the temple at affordable prices presenting the pleasant view of the outside village.

-Prepared by Bhavana Rathi of NewsGram. Twitter @tweet_bhavana 

Next Story

You May Soon Be Able to Prevent Chikungunya With Vaccines! IIT-Roorkee Researchers Discover Drug to Fight the Disease

At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease

0
64
cases of dengue
Dengue and Chikungunya are viral diseases transmitted to humans via infected mosquitoes. Pixabay

Roorkee, October 9, 2017 : Dengue and Chikungunya are known to strike fear in the country every year, so much so that the health graph of the city registers a steep rise in these cases. Both of the water-borne diseases, characterized by high fever and pain in the joints, take a toll on our lives. So far, there is no vaccine to immunize people against the spread of the Dengue and Chikungunya virus. However, researchers at IIT-Roorkee have now discovered that a commonly-utilized de-worming drug can be efficiently used for treatments against Chikungunya.

According to a report by PTI, Shailly Tomar, lead researcher and a professor at Indian Institute of Technology (IIT) Roorkee in Uttarakhand was quoted as saying, “Our research has shown that piperazine, a drug existing in the market, is successful in curbing the spread and replication of the Chikungunya virus in a lab setting.”

The drug, Piperazine, is usually used in de-worming treatments against round-words and pinworms. Using their expertise in virology and structure biology, experts have now discovered the anti-viral capabilities of the drug that can potentially prompt new therapies against the fatal, mosquito borne disease.

The researchers are currently testing the molecule on animals, and will consequently take it to clinical trials.

ALSO READ What preventive steps have the city Government taken to control Dengue and Chikungunya, asks the Delhi High Court

The molecular details uncovered in the study, which has been published in the journal Antiviral Research, will be additionally used to plan piperazine-derivative medications that are more compelling to fight against the Chikungunya virus.

Using X-ray crystallographic technique, in combination with computational science and fluorescence strategies, the researchers discovered that piperazine binds itself with the hydrophobic (water-hating) pocket of capsid protein present in the Chikungunya virus, which can reduce the spread of the virus.

“This pocket is key to the replication of the virus and its spread inside a host. Inhibiting the pocket prevents budding and spread of the virus and can help in treating the virus effectively using existing drugs,” Tomar said.

Chikungunya has become a major public health concern, with an increasing number of people being plagued by the disease every year.

 At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease. 

Developing a new anti-viral drug molecule can take up to 10 years. To tend to the disease on an immediate basis, Professor Tomar added, “We are looking at repositioning existing, approved drugs and testing these to see if they might inhibit or kill pathogenic viruses.”